Tremor
TrialsCompanies

Not investment advice.

Tremor shows what changed in public records. It never tells anyone to buy or sell. Many trial edits are harmless paperwork. Data from ClinicalTrials.gov, the SEC, and the Federal Register.

PrivacyTerms

VOR

Vor Biopharma Inc.

Tremor tracks 1 of its cancer trials.

Company-wide warning signs

These add points to every one of this company's trials.

None right now.

Trials

  • VORVor Biopharma
    0Calm

    A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)

    Running, no new patientsPhase 3191 patientsMain results: Mar 2027

Key executives leaving

From the last 12 months of the company's SEC reports.

None found.

Insider trades (last 6 months)

“Insiders” are executives, board members, and big shareholders. Many of their sales are pre-planned: scheduled months ahead under a legal plan (called 10b5-1), so they usually say little. Tremor only counts sales that weren't pre-planned.

1 sale (1 not pre-planned) · 0 purchases

  • RA CAPITAL MANAGEMENT, L.P.Large shareholder · Jul 16, 2026Sold 213 sharesabout $4 thousand · not pre-planned

Recent SEC filings

Public companies must report important news and their finances to the SEC, the US agency that oversees the stock market.

  • New shares being soldNew shares being sold (424B5)Oct 30, 2026
  • Quarterly reportQuarterly report (10-Q)Oct 30, 2026
  • Quarterly reportQuarterly report (10-Q)Aug 11, 2026
  • An executive or board member joined or leftNews report (8-K)Jul 7, 2026
  • News reportNews report (8-K)Jun 12, 2026

Money left

Coming soon: how many months of cash the company has, from its quarterly reports.
Shared information with investorsNews report (8-K)
Jun 8, 2026
  • Quarterly reportQuarterly report (10-Q)May 13, 2026